Lakeshore Biopharma CO (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 0 | 0 | 0 | 24,395 | 0 |
| Cost of Goods | N/A | N/A | N/A | 4,799 | N/A |
| Gross Profit | N/A | N/A | N/A | 19,596 | N/A |
| Operating Expenses | 0 | 0 | 0 | 30,090 | 0 |
| Operating Income | N/A | N/A | N/A | -9,695 | N/A |
| Interest Expense | 0 | 0 | 0 | 1,111 | 0 |
| Other Income | 0 | 0 | 0 | 1,101 | 0 |
| Pre-tax Income | 0 | 0 | 0 | -9,705 | 0 |
| Income Tax | N/A | N/A | N/A | -81 | N/A |
| Net Income Continuous | N/A | N/A | N/A | -9,624 | N/A |
| Net Income | $N/A | $N/A | $N/A | $-9,624 | $N/A |
| EPS Basic Total Ops | N/A | N/A | N/A | -1.00 | N/A |
| EPS Basic Continuous Ops | N/A | N/A | N/A | -1.03 | N/A |
| EPS Diluted Total Ops | N/A | N/A | N/A | -1.00 | N/A |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | -1.03 | N/A |
| EPS Diluted Before Non-Recurring Items | N/A | -1.20 | -0.16 | N/A | N/A |
| EBITDA(a) | $N/A | $N/A | $N/A | $-9,695 | $N/A |